LAGeT, Inc. and its subsidiary, LAGeT Musculoskeletal, LLC (the Company) have developed a technology process, termed LAGT (Light Activated Gene Therapy) for articular and meniscal cartilage repair, ligament and tendon healing and enhanced spinal fusion. The LAGT technology process was developed at the University of Rochester under the scientific leadership of Dr. Edward Schwarz, a team of orthopedic surgeons, and an optical engineer retained by the Company. The University of Rochester has filed patents on the LAGT process and its applications. The Company has received a worldwide exclusive license to these patents
